Trilations

Executive Summary

Trilations is a Belgium-based consulting firm that specializes in data-driven strategy and organizational transformation for the healthcare and energy/utilities sectors. Founded in 2018 and headquartered in Ghent, the company leverages advanced analytics and artificial intelligence to help life sciences companies build competitive healthcare strategies and improve customer engagement. Unlike a biotech developer, Trilations operates strictly as a service provider, focusing on market insights, operational excellence, and AI-powered solutions for its clients. While the firm is not involved in drug discovery or development, its expertise in data analytics positions it as a valuable partner for pharmaceutical and healthcare organizations seeking to optimize their go-to-market strategies. As a private company with no disclosed funding rounds or valuation, Trilations maintains a niche but stable position in the consulting landscape. Its recent inclusion in biopharmguy's database suggests growing visibility within the life sciences ecosystem. Given its service-oriented model, near-term financial catalysts are less pronounced than for product-focused biotechs, but the firm's ability to adapt to evolving industry trends—such as value-based care and digital transformation—could drive client demand and revenue growth. Overall, Trilations represents a low-risk, specialized advisory player rather than a high-upside investment opportunity.

Upcoming Catalysts (preview)

• H2 2026Launch of AI-Powered Strategy Platform for Pharma Clients55% success